BPT Crunch

Companies on the Cutting Edge of Healthcare Innovations

back to Marketplace

CureVac

CureVac logo

Founded
2000
Patents
51
Clinical Trials
16
Publications
53

Founded in 2000, the biopharmaceutical company CureVac is technology leader in the development of drugs that are based on the molecule Messenger RNA (mRNA). Here, the company follows the body’s own principle in which mRNA is used as a data carrier to instruct the human body to produce its own proteins capable of fighting a wide range of diseases. The RNA people pursue the ambitious goal of making the first mRNA-based drug available to people in need.

SHARE